Comparative Pharmacoeconomic Analysis of Rivaroxaban and Warfarin Usage in Patients With Non-Valvular Atrial Fibrillation

Jounal of arrhythmology
doi 10.35336/va-2019-3-37-47
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Institute of Cardio Technics - INCART

Related search

Under-Use of Warfarin for Patients With Non-Valvular Atrial Fibrillation in Japan

Internal Medicine
Internal MedicineMedicine
2004English

Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Hospital Length of Stay: Does Rivaroxaban Reduce Inpatient Stay Compared to Warfarin Among Patients With Non-Valvular Atrial Fibrillation?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Comparative Effectiveness and Safety of Warfarin and Dabigatran in Patients With Non-Valvular Atrial Fibrillation in Japan: A Claims Database Analysis

Journal of Cardiology
Cardiovascular MedicineCardiology
2019English

Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology
2012English

Primary and Secondary Prevention of Stroke and Systemic Embolism With Rivaroxaban in Patients With Non-Valvular Atrial Fibrillation

Heart and Vessels
Cardiovascular MedicineCardiology
2018English

Impact of Rivaroxaban Compared With Warfarin on the Coagulation Status in Japanese Patients With Non-Valvular Atrial Fibrillation: A Preliminary Analysis of the Prothrombin Fragment 1+2 Levels

Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy